Analyst Ratings for Tourmaline Bio (TRML)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 1.1 / 10
Percentile Rank: 8%
Rating Score: 1.1 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/15/2025 | BMO Capital | Kostas Biliouris | Downgrade | Market Perform (Outperform) |
48.00 (35.00) |
47.60 (47.98) |
0.8% | Details |
| 9/11/2025 | Piper Sandler | Yasmeen Rahimi | Downgrade | Neutral (Overweight) |
N/A (N/A) |
47.60 (47.98) |
0.8% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||



